News

#

Research Leveraging Neurolign published in Race Car Engineer

Neurolign’s Dx 100™ (formerly I-PAS) is leveraged by University of Cambridge researchers in collaboration with the world governing body for motorsport, the FIA [Federation Internationale de l’Automobile], and the FIA Foundation in their first prospective concussion research programme.

READ MORE
#

Neurolign Technologies Inc. to Present at Biotech Showcase™ 2020 in San Fransisco

Neurolign presenting company overview at BioTech Showcase

Toronto, ON, January 8, 2020 – Neurolign Technologies Inc. (“Neurolign”) has scheduled company presentations at Biotech Showcase™ 2020, to be held January 13–15, a critical event for healthcare innovation and investment at the Hilton San Francisco Union Square.

READ MORE
#

Neurolign Technologies Inc. Acquires Neuro Kinetics Inc.

On September 20th, 2019, Neurolign Technologies Inc. (“Neurolign”), announced the acquisition of Neuro Kinetics Inc. (“NKI”) of Pittsburgh, Pennsylvania. Neuro Kinetics Inc. is a leader in its field, providing eye-tracking diagnostic platforms that deliver, leading edge, neuro-functional assessments and monitoring to identify more than 200 diseases and medical conditions (www.neuro-kinetics.com).

READ MORE